Clinical Trial Update: Use of Silodosin to Treat Moderate to Severe Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating silodosin for abacterial chronic prostatitis/chronic pelvic pain syndrome has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pelvic Pain Syndrome
• Prostatitis

Drugs mentioned

• Rapaflo (silodosin)

Snippet

Sponsor: Watson Pharmaceuticals | Conditions: Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2012-02-24